These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25531249)

  • 1. DNA methylation is a key factor in understanding differentiation phenotype in esophageal squamous cell carcinoma.
    Komatsu M; Sasaki H
    Epigenomics; 2014; 6(6):567-9. PubMed ID: 25531249
    [No Abstract]   [Full Text] [Related]  

  • 2. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
    Ma K; Cao B; Guo M
    Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma.
    Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q
    Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
    Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
    Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.
    Rad A; Farshchian M; Forghanifard MM; Matin MM; Bahrami AR; Geerts D; A'rabi A; Memar B; Abbaszadegan MR
    Tumour Biol; 2016 Feb; 37(2):1715-25. PubMed ID: 26314854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT1-microRNA126 epigenetic circuit contributes to esophageal squamous cell carcinoma growth via ADAM9-EGFR-AKT signaling.
    Liu R; Gu J; Jiang P; Zheng Y; Liu X; Jiang X; Huang E; Xiong S; Xu F; Liu G; Ge D; Chu Y
    Clin Cancer Res; 2015 Feb; 21(4):854-63. PubMed ID: 25512445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Wang S; Liu X; Wang Z
    Tumour Biol; 2015 Aug; 36(8):5849-57. PubMed ID: 25724185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic alterations of the Igf2 promoter and the effect of miR‑483‑5p on its target gene expression in esophageal squamous cell carcinoma.
    Zhang H; Shi X; Chang W; Li Y; Wang L; Wang L
    Mol Med Rep; 2018 Feb; 17(2):2251-2256. PubMed ID: 29207103
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma.
    Li P; Liu X; Dong ZM; Ling ZQ
    Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.
    Du Z; Ma K; Sun X; Li A; Wang H; Zhang L; Lin F; Feng X; Song J
    World J Surg Oncol; 2015 Apr; 13():141. PubMed ID: 25886188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAX5 gene as a novel methylation marker that predicts both clinical outcome and cisplatin sensitivity in esophageal squamous cell carcinoma.
    Kurimoto K; Hayashi M; Guerrero-Preston R; Koike M; Kanda M; Hirabayashi S; Tanabe H; Takano N; Iwata N; Niwa Y; Takami H; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Sugimoto H; Fujii T; Fujiwara M; Kodera Y
    Epigenetics; 2017; 12(10):865-874. PubMed ID: 29099287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression analysis of iPS cell - inductive genes in esophageal squamous cell carcinoma by tissue microarray.
    Shimada Y; Okumura T; Sekine S; Moriyama M; Sawada S; Matsui K; Yoshioka I; Hojo S; Yoshida T; Nagata T; Fukuoka J; Tsukada K
    Anticancer Res; 2012 Dec; 32(12):5507-14. PubMed ID: 23225459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXF2 promoter methylation is associated with prognosis in esophageal squamous cell carcinoma.
    Chen X; Hu H; Liu J; Yang Y; Liu G; Ying X; Chen Y; Li B; Ye C; Wu D; Duan S
    Tumour Biol; 2017 Feb; 39(2):1010428317692230. PubMed ID: 28222662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.